OrganoBiotech, Inc.
OrganoBiotech accelerates drug discovery by combining organ-on-a-chip biology with machine learning. The OrganoPlatform enables scalable 3D perfusion tissue culture and high-throughput assays, supported by instrumentation and OrganoAssays for diverse disease models. Core technology includes Organ-on-a-Chip systems, machine learning analytics, and automated culture platforms. The company targets biotech and pharmaceutical researchers seeking faster, cost-efficient preclinical insights. Through its OrganoDrug initiative, it aims to improve the accuracy of preclinical testing and streamline drug development.
OrganoBiotech, Inc.
OrganoBiotech accelerates drug discovery by combining organ-on-a-chip biology with machine learning. The OrganoPlatform enables scalable 3D perfusion tissue culture and high-throughput assays, supported by instrumentation and OrganoAssays for diverse disease models. Core technology includes Organ-on-a-Chip systems, machine learning analytics, and automated culture platforms. The company targets biotech and pharmaceutical researchers seeking faster, cost-efficient preclinical insights. Through its OrganoDrug initiative, it aims to improve the accuracy of preclinical testing and streamline drug development.